MetLife Investment Management’s Monro MNRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Buy
15,697
+2,011
+15% +$32.9K ﹤0.01% 2271
2026
Q1
$220K Sell
13,686
-3,392
-20% -$65.9K ﹤0.01% 2180
2025
Q4
$342K Sell
17,078
-290
-2% -$5.34K ﹤0.01% 1977
2025
Q3
$312K Sell
17,368
-336
-2% -$5.51K ﹤0.01% 2060
2025
Q2
$264K Hold
17,704
– – ﹤0.01% 2028
2025
Q1
$256K Sell
17,704
-295
-2% -$5.64K ﹤0.01% 2068
2024
Q4
$446K Hold
17,999
– – ﹤0.01% 1860
2024
Q3
$519K Hold
17,999
– – ﹤0.01% 1764
2024
Q2
$429K Buy
17,999
+1,746
+11% +$46.6K ﹤0.01% 1803
2024
Q1
$513K Hold
16,253
– – ﹤0.01% 1659
2023
Q4
$477K Hold
16,253
– – ﹤0.01% 1713
2023
Q3
$451K Hold
16,253
– – ﹤0.01% 1696
2023
Q2
$660K Hold
16,253
– – ﹤0.01% 1509
2023
Q1
$803K Buy
16,253
+233
+1% +$11.6K 0.01% 1348
2022
Q4
$724K Sell
16,020
-1,354
-8% -$62.5K 0.01% 1400
2022
Q3
$755K Hold
17,374
– – 0.01% 1342
2022
Q2
$745K Hold
17,374
– – 0.01% 1384
2022
Q1
$770K Buy
17,374
+6,138
+55% +$299K 0.01% 1492
2021
Q4
$655K Sell
11,236
-1,403
-11% -$82.9K 0.01% 1354
2021
Q3
$727K Hold
12,639
– – 0.01% 1302
2021
Q2
$803K Hold
12,639
– – 0.01% 1294
2021
Q1
$832K Sell
12,639
-1,932
-13% -$121K 0.01% 1249
2020
Q4
$777K Hold
14,571
– – 0.01% 1246
2020
Q3
$591K Hold
14,571
– – 0.01% 1281
2020
Q2
$801K Hold
14,571
– – 0.01% 1116
2020
Q1
$638K Hold
14,571
– – 0.01% 1080
2019
Q4
$1.14M Hold
14,571
– – 0.01% 1032
2019
Q3
$1.15M Hold
14,571
– – 0.01% 999
2019
Q2
$1.24M Sell
14,571
-25,947
-64% -$2.16M 0.01% 1012
2019
Q1
$3.51M Buy
40,518
+27,012
+200% +$2.04M 0.01% 993
2018
Q4
$929K Hold
13,506
– – 0.01% 1044
2018
Q3
$940K Sell
13,506
-1,564
-10% -$107K 0.01% 1158
2018
Q2
$876K Hold
15,070
– – 0.01% 1078
2018
Q1
$808K Hold
15,070
– – 0.01% 1104
2017
Q4
$858K Buy
+15,070
New +$785K 0.01% 1093

Other funds holding MNRO

MetLife Investment Management's MNRO Position: Q2 2026 in Review

MetLife Investment Management increased its Monro (MNRO) stake by 15% in Q2 2026, buying an estimated $32.9K and bringing the position to 15,697 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #2271.

MetLife Investment Management first reported a position in MNRO in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.51M in Q1 2019. 180 funds tracked by Wall St. Rank hold MNRO as of Q2 2026.

  • MetLife Investment Management held 15,697 shares of Monro worth $269K as of Q2 2026.
  • MetLife Investment Management bought 2,011 Monro shares in Q2 2026, an estimated $32.9K.
  • Monro made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2271 holding.
  • MetLife Investment Management first reported a position in Monro in Q4 2017 and has held it in 35 quarters since.
  • MetLife Investment Management's Monro position peaked at $3.51M in Q1 2019.
  • 180 funds tracked by Wall St. Rank held Monro as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.